acyclovir
Generic: acyclovir
Labeler: a-s medication solutionsDrug Facts
Product Profile
Brand Name
acyclovir
Generic Name
acyclovir
Labeler
a-s medication solutions
Dosage Form
TABLET
Routes
Active Ingredients
acyclovir 400 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
50090-7275
Product ID
50090-7275_810fa4f4-8281-44c0-98c2-a3cc70098fab
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA210401
Listing Expiration
2026-12-31
Marketing Start
2023-06-20
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
500907275
Hyphenated Format
50090-7275
Supplemental Identifiers
RxCUI
UNII
NUI
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
acyclovir (source: ndc)
Generic Name
acyclovir (source: ndc)
Application Number
ANDA210401 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 400 mg/1
Packaging
- 25 TABLET in 1 BOTTLE (50090-7275-2)
- 50 TABLET in 1 BOTTLE (50090-7275-3)
- 15 TABLET in 1 BOTTLE (50090-7275-4)
- 30 TABLET in 1 BOTTLE (50090-7275-5)
- 60 TABLET in 1 BOTTLE (50090-7275-6)
- 45 TABLET in 1 BOTTLE (50090-7275-9)
Packages (6)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "810fa4f4-8281-44c0-98c2-a3cc70098fab", "openfda": {"nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "unii": ["X4HES1O11F"], "rxcui": ["197311"], "spl_set_id": ["c0c29e0f-b6e2-49df-88d1-95b7b625d356"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "25 TABLET in 1 BOTTLE (50090-7275-2)", "package_ndc": "50090-7275-2", "marketing_start_date": "20241008"}, {"sample": false, "description": "50 TABLET in 1 BOTTLE (50090-7275-3)", "package_ndc": "50090-7275-3", "marketing_start_date": "20241008"}, {"sample": false, "description": "15 TABLET in 1 BOTTLE (50090-7275-4)", "package_ndc": "50090-7275-4", "marketing_start_date": "20241008"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (50090-7275-5)", "package_ndc": "50090-7275-5", "marketing_start_date": "20241008"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (50090-7275-6)", "package_ndc": "50090-7275-6", "marketing_start_date": "20241008"}, {"sample": false, "description": "45 TABLET in 1 BOTTLE (50090-7275-9)", "package_ndc": "50090-7275-9", "marketing_start_date": "20241008"}], "brand_name": "Acyclovir", "product_id": "50090-7275_810fa4f4-8281-44c0-98c2-a3cc70098fab", "dosage_form": "TABLET", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "50090-7275", "generic_name": "Acyclovir", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Acyclovir", "active_ingredients": [{"name": "ACYCLOVIR", "strength": "400 mg/1"}], "application_number": "ANDA210401", "marketing_category": "ANDA", "marketing_start_date": "20230620", "listing_expiration_date": "20261231"}